The study confirmed FOXO4-DRI was effective across senescent cells generated by different methods (irradiation, doxorubicin, and replication stress), and documented that pre-treatment with FOXO4-DRI attenuated the dedifferentiation of chondrocytes during in vitro expansion establishing it as a valuable tool for research into senescent cell biology in cartilage and musculoskeletal models
It is a research compound and is not FDA-approved
Potential side effects from unofficial reports reveal that BPC-157 may: speed up cancer growth in cancer patients dizziness flushing racing heart blood pressure changes mood swings Currently, all available animal studies do not report any potential side effects of toxicity of BPC -157
It helps neutralize harmful free radicals in the body, which are unstable molecules that can cause oxidative stress and damage cells
Atrium Innovations has over 1,100 employees and operates seven manufacturing facilities
Copper peptides don't address acne - they aren't meant to